Clinical trial

Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy…

NCT00331760 · Radiation Therapy Oncology Group, Other · Completed

Key facts

NCT number NCT00331760
Title Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Official title A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) to the Pelvis ± Chemotherapy for Post-Operative Patients With Either Endometrial or Cervical Carcinoma
Lead sponsor Radiation Therapy Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH NRG Oncology
Status Completed
Phase Phase 2
Study type Interventional
Conditions Cervical Cancer, Endometrial Cancer
Intervention type Drug, Radiation
Interventions cisplatin, intensity-modulated radiation therapy
Enrollment 106
Start date Mar 1, 2006
Primary completion Feb 1, 2009
Completion Dec 1, 2016
First posted May 31, 2006
Last update posted Feb 26, 2019
Countries Canada, United States

At a glance

  • 100–999 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies